BMEA — Biomea Fusion Income Statement
0.000.00%
Last trade - 00:00
- $284.25m
- $170.96m
- 26
- 12
- 28
- 11
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Total Operating Expenses | 1.2 | 5.33 | 41.7 | 83.6 | 126 |
Operating Profit | -1.2 | -5.33 | -41.7 | -83.6 | -126 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -1.2 | -5.32 | -41.6 | -81.8 | -117 |
Net Income After Taxes | -1.2 | -5.32 | -41.6 | -81.8 | -117 |
Net Income Before Extraordinary Items | |||||
Net Income | -1.2 | -5.32 | -41.6 | -81.8 | -117 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1.2 | -5.32 | -41.6 | -81.8 | -117 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.042 | -0.185 | -1.74 | -2.8 | -3.44 |
Dividends per Share |